최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국임상약학회지 = Korean journal of clinical pharmacy, v.28 no.4, 2018년, pp.308 - 319
김호정 (영남대학교 약학대학) , 이인향 (영남대학교 약학대학)
Background: Some mental illnesses such as depression are known to be one of the risk factors of suicide and proper antidepressant therapy can reduce suicidal behavior. Objectives: This study aimed to analyze regional variations in antidepressant consumption and adherence, suicide rate, prevalence of...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
우리나라의 자살률은 어떻게 기록되고 있는가? | 우리나라의 자살률은 2013년 기준 표준인구 10만 명당 29.1명으로, OECD 회원국 평균 자살률 12.0명과 비교했을 때 2배 이상 높은 수준을 기록하고 있으며, 이러한 높은 자살률은2003년부터 10년 이상 장기간 지속되어 왔다.1) 자살이 개인의 삶에 부정적인 영향을 미칠 뿐만 아니라 국가 및 사회의 경쟁력과 발전을 저해한다는 점에서, 우리나라의 높은 자살률은 우리 사회가 당면한 심각한 사회 문제로 끊임없이 대두되어왔다. | |
정신질환 유병률과 자살률은 어느 지역이 더 높게 나타나는가? | 본 연구의 결과는 일반적인 예상과 다른 양상으로 농어촌과 소도시 등이 포함된 광역도 지역에서 광역시 이상 지역보다 연구대상 정신질환 유병률과 자살률이 높은 것을 확인할 수 있었다. 광역도 지역인 전라도, 강원도는 연구대상 정신질환 유병률과 자살률이 높고 항우울제 투약순응도가 낮았다. | |
우리나라에서 정신질환에 대한 약물치료법의 현황은? | 관련 정신질환을 앓고 있는 이가 자살에 이르지 않도록 하기 위해서는 다방면에서 꾸준한 관리가 요구되며, 특히 약물치료법이 중요한 부분을 맡고 있다.9,10) 그러나 최근 보고에 따르면 관련 질환의 주요 치료제인 항우울제의 국내 소비량은 OECD 국가 중 두 번째로 낮은 20DDD/1,000명/일로 OECD평균 항우울제 소비량 58DDD/1,000/일과 비교했을 때 3분의1수준에 그치고 있다.1) 자살률 감소에 있어 항우울제 사용의 효과를 규명한 선행연구의 결과를 고려할 때11) 우리나라의 낮은 항우울제 소비량은 약물치료를 통한 주요 자살요인이 되는 정신질환의 관리가 적절히 이뤄지고 있는가에 대해 의문을 갖게 한다. |
Organisation for Economic Co-operation and Development. Paris: Health at a glance 2015; 2015 Oct. Available from https://doi.org/10.1787/19991312. Accessed Mar 17, 2017.
Lee H, Myung W, Lee C, et al. Clinical epidemiology of long-term suicide risk in a nationwide population-based cohort study in South Korea. J. Psychiatr Res 2018;100:47-55.
Ministry for Health Welfare and Family Affairs. Suicide prevention comprehensive measures (2nd edition). Ministry for Health Welfare and Family Affairs 2008; 1-86.
Thomson W. Long term follow up of suicide in a clinically depressed community sample. Journal of Affective Disorders 2012;139(1):52-55.
Indu PS, Anilkumar TV, Pisharody R, et al. Prevalence of depression and past suicide attempt in primary care. Asian J Psychiatr 2017;27:48-52.
Hawton K, Casanas ICC, Haw C, et al. Risk factors for suicide in individuals with depression: A systematic review. J Affect Disord 2013;147(1-3):17-28.
Vander Stoep A, Adrian M, McCauley E, et al. Risk for suicidal ideation and suicide attempts associated with co-occurring depression and conduct problems in early adolescence. Suicide Life Threat Behav 2011;41(3):316-29.
Nrugham L, Holen A, Sund AM. Suicide attempters and repeaters: Depression and coping: A prospective study of early adolescents followed up as young adults. J Nerv Ment Dis 2012;200(3):197-203.
Hirschfeld RM. The epidemiology of depression and the evolution of treatment. J Clin Psychiatry 2012;73(1):5-9.
Zhou X, Michael KD, Liu Y, et al. Systematic review of management for treatment-resistant depression in adolescents. BMC psychiatry 2014;14:340.
Castelpietra G, Gobbato M, Valent F, et al. Antidepressant use in suicides: A case-control study from the Friuli Venezia Giulia Region, Italy, 2005-2014. Eur J Clin Pharmacol 2017;73(7):883-90.
Sawada N, Uchida H, Suzuki T, et al. Persistence and compliance to antidepressant treatment in patients with depression: A chart review. BMC psychiatry 2009;9:38.
Yau WY, Chan MC, Wing YK, et al. Noncontinuous use of antidepressant in adults with major depressive disorders -a retrospective cohort study. Brain Behav 2014;4(3):390-7.
Bushnell GA, Sturmer T, White A, et al. Predicting persistence to antidepressant treatment in administrative claims data: Considering the influence of refill delays and prior persistence on other medications. J Affect Disord 2016;196:138-47.
Ho SC, Chong HY, Chaiyakunapruk N, et al. Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review. J Affect Disord 2016;193:1-10.
Keyloun KR, Hansen RN, Hepp Z, et al. Adherence and persistence across antidepressant therapeutic classes: A retrospective claims analysis among insured us patients with major depressive disorder (mdd). CNS Drugs 2017;31(5):421-32.
Henein F, Prabhakar D, Peterson EL, et al. A prospective study of antidepressant adherence and suicidal ideation among adults. The primary care companion for CNS disorders 2016;18(6).
Ruengorn C, Sanichwankul K, Niwatananun W, et al. Factors related to suicide attempts among individuals with major depressive disorder. Int J Gen Med 2012;5:323-30.
Park J. Socioeconomic inequalities in health at the regional level in Korea. Korea Institute for Health and Social Affairs 2018;1-18.
Kim Y-M, Kang S-H. Changes and determinants affecting on geographic variations in health behavior, prevalence of hypertension and diabetes in Korean. Journal of Digital Convergence 2015;13(11):241-54.
Jeong H-E, Cho P-K. A study about the prevalence and the related factors of metabolic syndrome and fatty liver comparing the urban area to the industrial area. J Korean Soc Radiol 2016;39:361-68.
Kessing LV. Severity of depressive episodes according to icd-10: Prediction of risk of relapse and suicide. Br J Psychiatry 2004;184:153-6.
Kim N, Kim K, Lee S, et al. Status and quality of medical use of depression patients. Health Insurance Review & Assessment Service; 2008;1-215.
Heo D, Lee S, Ahn J, et al. Current situation of burden and treatment of diseases of domestic depression. National Evidence-based Healthcare Collaborating Agency 2011;1-98.
Ahn J, Han C, Woo J, et al. Understanding the current state of research on mental illness in Korea and research on suicide by depression. National Evidence-based Healthcare Collaborationg Agency 2012;1-485.
Lee S, Baek J, Yoon Y, et al. Analysis of socioeconomic impact of mental health problems and research on management strategies -focusing on depression-. National Health Insurance Service 2013;1-270.
World Health Organization. Definition and general considerations 2017. Available from https://www.whocc.no/ddd/definition_and_general_considera/. Accessed Oct 17, 2017.
Kang H-Y, Kwon J-W, Bae S-J, et al. Administrative and managerial pharmacy. Korean Assosiation of Pharmacy Education 2013; 204.
Korean Statistical Information Service. Cause of death. Available from http://kosis.kr/statHtml/statHtml.do?orgId101&tblIdDT_1B34E13&conn_pathI2. Accessed Aug 25, 2018.
Choi H, Kim H. Analysis of the relationship between community characteristics and depression using geographically weighted regression. Epidemiology and health 2017;39.
Ministry for Health and Welfare, Health Insuracne Review & Assessment Services. Pharmaceutical consumption and sales statistics for 2016. Ministry for Health and Welfare, Health Insurance Review & Assessment Services 2017;1-177.
Ministry of Health and Welfare. National health and medical statistics 2017;1-622.
Park H. Difference of depression prevalence by demographic characteristic, urban-rural and type of health insurance using HIRA-NPS data. M.S. Thesis for Sungkyunkwan University, 2017.
Lee MS, Lee HY, Kang SG, et al. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders. J Affect Disord 2010;123(1-3):216-21.
Ahn J. Depression, suicide, and Korean society. J Korean Med Assoc 2012;55(4):320-21.
Park C, Nam BW. Prevalence of depressive disorder among the elderly attending community health center in a small city. Int Psycogeriatr 2013;25(6):S126-S27.
Jun JA. Gender differences in mental health of Korean adults: Focusing on depression. Health Welf Policy Forum 2014:17-26.
Cho SJ, Oh DH, Lee JA, et al. Prevalence of main psychiatric disorders in relation to urbanization in Gyeonggi province by using the Korean version of the mini-international neuropsychiatric interview. J Korean Neuropsychiatr Assoc 2011;50(4):288-96.
Jung S-J, Lee S-S, Lee KE, et al. Perception and attitude towards antidepressants in Koreans. Korean J Clin Pharm 2012;22(1):65-72.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.